Almirall (WBO:ALM) Total Liabilities : €831.0 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Almirall Total Liabilities?

Almirall's Total Liabilities for the quarter that ended in Mar. 2024 was €831.0 Mil.

Almirall's quarterly Total Liabilities increased from Jun. 2023 (€818.58 Mil) to Dec. 2023 (€911.59 Mil) but then declined from Dec. 2023 (€911.59 Mil) to Mar. 2024 (€831.00 Mil).

Almirall's annual Total Liabilities declined from Dec. 2021 (€855.71 Mil) to Dec. 2022 (€828.98 Mil) but then increased from Dec. 2022 (€828.98 Mil) to Dec. 2023 (€911.59 Mil).

Almirall Total Liabilities Historical Data

The historical data trend for Almirall's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Almirall Total Liabilities Chart

Almirall Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

1,159.60

988.15

855.71

828.98

911.59

Almirall Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22	Mar23	Jun23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															828.98	803.80	818.58	911.59	831.00

Almirall Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Almirall's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	351.075	+	(386.036	+	113.993
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	60.481)
	=	911.6

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	2374.985	-	1463.4
	=	911.6

Almirall's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	259.6	+	(352.3	+	219.1
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	831.0

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	2307.2	-	1476.2
	=	831.0

Almirall Total Liabilities Related Terms

Thank you for viewing the detailed overview of Almirall's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Almirall (WBO:ALM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Almirall SA (WBO:ALM) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

LBTSF:USA 0O9B:UK ALM:Spain E2Z:Germany

Address

Ronda General Mitre 151, Barcelona, ESP, 08022

Website

http://www.almirall.es

Almirall SA is a Spain-based company engaged in development, manufacture, and selling pharmaceutical products across a range of therapeutic areas. It aims to provide treatments in areas of dermatology, respiratory, gastrointestinal, central nervous systems, and other specialties. The company operates in five segments: Sales of its own network, sales of licensees, Research and developments, Sales of Therapeutic dermatological products in the U.S., and Corporate management. The medical dermatology business in the Europe is the key driver of the company's operation. Other than Europe, the company also operates in the Americas, Asia, Africa, and Oceania through subsidiaries.

Almirall (WBO:ALM) Headlines

From GuruFocus

ALFI Inc: A Little Known Yet Compelling Ad-Tech Play

By Ishan Majumdar Ishan Majumdar • 05-07-2021

Alfi: Solid Growth Potential Lies Ahead

By Ishan Majumdar Ishan Majumdar • 06-02-2021